Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 1026-1034

  Muzykantov, Vladimir R ^a,c   Barnathan, Elliot S ^a   Atochina, Elena N ^a   Kuo, Alice ^a   Danilov, Sergei M ^b   Fisher, Aron B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME MONOCLONAL ANTIBODY 9B9; ANTIBODY CONJUGATE; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR; STREPTAVIDIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG SPECIFICITY; DRUG TARGETING; FIBRINOLYTIC THERAPY; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; MALE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; LUNG; MICE; PLASMINOGEN ACTIVATORS; PULMONARY EMBOLISM; RATS; RATS, SPRAGUE-DAWLEY; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE DISTRIBUTION;

EID: 0030433178     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BARNATHAN, E., KUO, A., VAN DER KEYL, H., MCCRAE, K., LARSEN, G. AND CINES, D.: Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites. J. Biol. Chem. 236: 7792-7799, 1988.
2. CALDWELL, P., SEEGAL, B., HSU, K., DAS, M. AND SOFFER, R.: Angiotensin-converting enzyme: vascular endothelial localization. Science 191: 1050-1051, 1976.
3. DANILOV, S., MUZYKANTOV, V., MARTYNOV, A., ATOCHINA, E., SAKHAROV, I., TRAKHT, I. AND SMIRNOV, V.: Lung is a target organ for monoclonal antibody to ACE. Lab. Invest. 64: 118-124, 1991.
4. DANILOV, S., ATOCHINA, E., HIEMISH, H., CHURAKOVA, T., MOLDOBAYEVA, A., SAKHAROV, I., DEICHMAN, G., RYAN, U. AND MUZYKANTOV, V.: Interaction of monoclonal antibody to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo. Int. Immunol. 6: 1131-1160, 1994.
5. ERDOS, E.: Angiotensin-converting enzyme and changes of our concepts through the years. Hypertension 16: 363-370, 1990.
6. FEARS, R. AND POSTE, G.: Obstacles to the development of novel thrombolytic agents for acute myocardial infarction therapy. Fibrinolysis 8: 203-213, 1944.
7. HIGAZI, A., COHEN, R., HENKIN, J., KNISS, D., SCHWARTZ, B. AND CINES, D.: Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J. Biol. Chem. 270: 17375-17380, 1995.
8. KAJIHARA, J., SHIBATA, K., NAKANO, Y., NISHIMURO, S. AND KATO, K.: Physicochemical characterization of PEG-PPG conjugated human urokinase. Biochim. Biophys. Acta 1199: 202-208, 1994.
9. KHAW, B., STRAUSS, H., NARULA, J.: "Magic bullets": From muskets to smart bombs! J. Nucleic Med. 34: 2264-2268, 1993.
10. KRISHNAMURTI, C., KEYT, B., MAGLASANG, P. AND ALVING, B.: PAI-1-resistant tPA: Low doses prevent fibrin deposition in rabbits with increased PAI-1 activity. Blood 87: 14-19, 1996.
11. LUNEN, R. AND COLLEN, D.: Remaining perspectives of mutant and chimeric plasminogen activators. Ann. N.Y. Acad. Sci. 667: 357-364, 1992.
12. MUZYKANTOV, V., SAKHAROV, D., SMIRNOV, M., SAMOKHIN, G. AND SMIRNOV, V.: Immunotargeting of erythrocyte-bound streptokinase provides local lysis of fibrin clot. Biochim. Biophys. Acta 884: 355-363, 1986.
13. MUZYKANTOV, V., MARTYNOV, A., PUCHNINA, E. AND DANILOV, S.: In vivo administration of glucose oxidase conjugated with monoclonal antibody to human ACE. Am. Rev. Respir. Dis. 136: 1464-1473, 1989.
14. MUZYKANTOV, V., PUCHNINA, E., ATOCHINA, E., HIEMISH, H., SLINKIN, M., MEERTZUK, F. AND DANILOV, S.: Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to ACE. J. Nucleic Med. 32: 453-460, 1991.
15. MUZYKANTOV, V., ATOCHINA, E., GAVRILJUK, V., DANILOV, S. AND FISHER, A. B.: Immunotargeting of streptavidin to the pulmonary endothelium. J. Nucleic Med. 35: 1358-1365, 1994.
16. MUZYKANTOV, V. AND DANILOV, S.: Targeting of radiolabeled monoclonal antibody against ACE to the pulmonary endothelium. In Targeted Delivery of Imaging Agents, ed. by V. Torchilin, pp. 465-485, Boca Raton, FL, CRC Press, 1995.
17. MUZYKANTOV, V., GAVRILUK, V., REINECKE, A., ATOCHINA, E., KUO, A., BARNATHAN, E. AND FISHER, A. B.: The functional effects of biotinylation of anti-ACE monoclonal antibody in terms of its targeting in vivo. Anal. Biochem. 226: 279-287, 1995.
18. MUZYKANTOV, V., ATOCHINA, E., ISCHIROPOULOS, H., DANILOV, S. AND FISHER, A. B.: Immunotargeting of antioxidant enzymes to the pulmonary endothelium. Proc. Natl. Acad. Sci. U.S.A. 93: 5213-5218, 1996.
19. MUZYKANTOV, V., ATOCHINA, E., KUO, A., BARNATHAN, E., NOTARFRANCESCO, K., SHUMAN, H., DODIA, C. AND FISHER, A. B.: Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme. Am. J. Physiol. 270: L704-L713, 1996.
20. PLOW, E., HERREN, T., REDLITZ, A., MILES, L. AND HOOVER-PLOW, J.: The cell biology of plasminogen system. FASEB J. 9: 939-945, 1995.
21. PREWITT, R.: Principles of thrombolysis in pulmonary embolism. Chest 99: 157-164, 1991.
22. RUNGE, M., BODE, C., HABER, E. AND QUETERMOUS, T.: Hybrid molecules: insights into plasminogen activator function. Mol. Biol. Med. 8: 245-255, 1991.
23. SERRANO, R., RODRIGUEZ, P., PIZZO, S. AND GONZALEZ-GRONOW, M.: ATP-regulated activity of plasmin-streptokinase complex: a novel mechanism involving phosphorilation of streptaokinase. Biochem. J. 313: 171-177, 1996.
24. TAPSON, V., GURBEL, P., WITTY, L., PIEPER, K. AND STACK, R.: Pharmacomechanical thrombolysis of experimental pulmonary emboli. Chest 106: 1558-1562, 1994.
25. VERSTRAETE, M. AND LIJNEN, H.: Novel thrombolytic agents. Cardiovasc. Drugs Therapy 8: 801-811, 1994.
26. WILCHEK, M. AND BAYER, E.: The avidin-biotin complex in bioanalytical research. Anal. Biochem. 171: 1-32, 1988.